Skip to main content
Skip to main content
NH logo

NantHealth, Inc. (NH) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

DELISTED 2025

What happened to NantHealth, Inc. (NH) stock?

NantHealth, Inc. (NH) no longer trades on public markets. It was delisted in January 2025. The figures below are historical and are not a current quote.

Vol: 198.0K| 52-wk range: $1.35 – $2.39
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

NantHealth, Inc. (NH). NantHealth, Inc. is a healthcare IT company focused on delivering clinical decision support and improving payer-provider communication. Their key offerings include the Eviti platform and NaviNet suite, aiming to streamline healthcare processes and enhance outcomes. Sector: Healthcare.

Last analyzed: May 10, 2026
NantHealth, Inc. is a healthcare IT company focused on delivering clinical decision support and improving payer-provider communication. Their key offerings include the Eviti platform and NaviNet suite, aiming to streamline healthcare processes and enhance outcomes.

Analyst Coverage for NH: NH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NH against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the NH film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 45/100 · C

NH: 1/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Unfavorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

NantHealth, Inc. (NH) Healthcare & Pipeline Overview

CEOPatrick Soon-Shiong F.A.C.S., FACS, FRCS (C),
Employees365
HeadquartersMorrisville, NC, US
IPO Year2016

NantHealth, Inc. provides healthcare IT solutions, including clinical decision support and payer-provider communication platforms, primarily through its Eviti and NaviNet offerings. The company aims to improve healthcare efficiency and outcomes by centralizing clinical content and streamlining administrative processes within the healthcare ecosystem in the US, Canada, and the UK.

Data Provenance | Financial Data Quantitative Analysis Analysis: May 10, 2026

What Is the Investment Thesis for NH?

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

NantHealth, Inc. operates in the healthcare IT sector, which is experiencing growth due to the increasing demand for efficient data management and streamlined communication between healthcare providers and payers. The company's Eviti and NaviNet platforms address critical needs in cancer care management and payer-provider collaboration. However, with a profit margin of -101.2%, the company needs to demonstrate a clear path to profitability. Key catalysts include expanding the adoption of Eviti Connect for pre-authorization automation and leveraging NaviNet AllPayer to capture a larger share of the payer-provider communication market. The investment thesis hinges on NantHealth's ability to scale its SaaS solutions and achieve operational efficiencies to improve its financial performance.

Based on FMP financials and quantitative analysis

NH Key Highlights

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

NantHealth operates in the healthcare IT sector, focusing on clinical decision support and payer-provider communication.

  • The company's Eviti platform offers SaaS-based clinical decision support, centralizing treatment data and cost information.
  • NaviNet is a suite of SaaS solutions designed to streamline communication between payers and providers.
  • NantHealth's profit margin is -101.2%, indicating significant losses relative to revenue.
  • Gross margin stands at 57.0%, suggesting potential for profitability with improved operational efficiency.

Who Are NH's Competitors?

NH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
VEEV Veeva Systems Inc. $263.67 +1.10% $42.8B 905-pillar
GEHC GE HealthCare Technologies Inc. $64.24 -1.43% $29.0B 595-pillar
BTSG BrightSpring Health Services, Inc. $57.88 -6.63% $11.4B 695-pillar
TEM Tempus AI, Inc. $59.25 -3.30% $10.4B 315-pillar
TXG 10x Genomics, Inc. $66.38 -1.35% $8.43B 395-pillar
HQY HealthEquity, Inc. $95.70 +1.22% $8.00B 905-pillar
MTHRY M3, Inc. $5.40 +2.86% $7.20B 519-signal
HNGE Hinge Health, Inc. $90.08 -1.35% $6.97B 905-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are NH's Key Strengths?

Comprehensive clinical decision support with Eviti platform.

  • Established payer-provider communication platform with NaviNet.
  • SaaS-based business model provides recurring revenue.
  • Offers data analytics solutions through Quadris.

What Are NH's Weaknesses?

Negative profit margin (-101.2%) indicates financial instability.

  • High beta (1.82) suggests high volatility compared to the market.
  • Dependence on NantWorks, LLC.
  • Limited geographic presence compared to larger competitors.

What Could Drive NH Stock Higher?

Expansion of Eviti Connect adoption for pre-authorization automation among payers.

  • Increasing NaviNet AllPayer reach to more commercial and government plans to streamline provider communication.
  • Leveraging Quadris data solutions to provide actionable insights to healthcare providers and payers.
  • Strategic partnerships with EHR vendors and population health management companies to expand product offerings.

What Are the Key Risks for NH?

Financial-distress signal — its Altman Z-Score of -13.11 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Intense competition from established healthcare IT vendors like Allscripts and Cerner.
  • Regulatory changes in healthcare impacting reimbursement and data privacy (e.g., HIPAA).
  • Cybersecurity threats and data breaches compromising patient data.
  • Negative profit margin (-101.2%) raises concerns about financial sustainability.
  • Economic downturn affecting healthcare spending and IT investments.

What Are the Growth Opportunities for NH?

  • Expansion of Eviti Connect: NantHealth can drive growth by expanding the adoption of Eviti Connect, its pre-authorization automation solution for cancer care. The market for pre-authorization automation is growing as payers seek to streamline administrative processes and reduce costs. By demonstrating the value of Eviti Connect in improving efficiency and reducing denial rates, NantHealth can capture a larger share of this market. Timeline: Ongoing.
  • Increased Adoption of NaviNet AllPayer: NaviNet AllPayer provides eligibility, benefit, and claim status information to provider offices, streamlining communication with payers. The market for payer-provider communication platforms is expanding as healthcare providers seek to reduce administrative burdens and improve revenue cycle management. By expanding the reach of NaviNet AllPayer to more commercial and government plans, NantHealth can increase its market share. Timeline: Ongoing.
  • Leveraging Quadris Data Solutions: NantHealth's Quadris data solution offers multi-data analysis, reporting, and professional services. The market for healthcare data analytics is growing as healthcare organizations seek to improve clinical outcomes, reduce costs, and optimize operations. By leveraging Quadris to provide actionable insights to healthcare providers and payers, NantHealth can drive revenue growth. Timeline: Ongoing.
  • Strategic Partnerships and Integrations: NantHealth can pursue strategic partnerships and integrations with other healthcare IT vendors to expand its reach and enhance its product offerings. For example, integrating Eviti with leading EHR systems can improve clinical decision support and drive adoption. Partnering with population health management companies can enhance NantHealth's data analytics capabilities. Timeline: Ongoing.
  • Geographic Expansion: NantHealth currently operates in the United States, Canada, and the United Kingdom. Expanding into new geographic markets, such as Europe and Asia-Pacific, can drive revenue growth. These markets offer significant opportunities for healthcare IT solutions that improve efficiency and outcomes. However, geographic expansion requires careful planning and execution to navigate regulatory and cultural differences. Timeline: Unknown.

What Are NH's Competitive Advantages?

  • Proprietary Technology: NantHealth's Eviti platform has a comprehensive library of evidence-based treatment standards and protocols.
  • Established Customer Base: The company has an established customer base of healthcare providers and payers.
  • Data Network Effects: The NaviNet platform benefits from network effects as more payers and providers join the platform, increasing its value to all users.

What Does NH Do?

NantHealth, Inc., established in 2010 and headquartered in Morrisville, North Carolina, operates as a healthcare IT company with a focus on delivering solutions that enhance clinical decision support and streamline payer-provider communication. As a subsidiary of NantWorks, LLC, NantHealth has evolved to offer a suite of software and data solutions designed to improve healthcare efficiency and outcomes. Its flagship product, Eviti, is a SaaS-based clinical decision support solution that centralizes clinical content, treatment cost data derived from Medicare reimbursements, and treatment toxicity data. Eviti is complemented by Eviti Connect, which automates pre-authorization processes to help payers and providers navigate the complexities of cancer care, and Eviti Advisor, which provides physicians with access to evidence-based treatment standards and protocols. NantHealth also offers NaviNet, a suite of SaaS-based solutions that streamline communication and consolidate information between payers and providers. This includes NaviNet Open, a payer-provider collaboration platform, and NaviNet AllPayer, which provides eligibility, benefit, and claim status information for commercial and government plans, including Medicare beneficiaries. Additionally, the company provides OpenNMS, an open-source network monitoring solution for enterprise-grade networks, and Quadris, a data solution offering multi-data analysis, reporting, and professional services. NantHealth serves healthcare providers, payers, and other stakeholders across the United States, Canada, and the United Kingdom, aiming to improve healthcare delivery through technology.

What Products and Services Does NH Offer?

  • Offers Eviti, a SaaS-based clinical decision support solution for cancer treatment.
  • Provides Eviti Connect, which automates pre-authorization for cancer care.
  • Offers Eviti Advisor, providing physicians access to evidence-based treatment protocols.
  • Delivers NaviNet, a suite of SaaS-based solutions for payer-provider communication.
  • Provides NaviNet Open, a payer-provider collaboration platform.
  • Offers NaviNet AllPayer, providing eligibility and claim status information.
  • Provides OpenNMS, an open-source network monitoring solution.
  • Offers Quadris, a data solution for multi-data analysis and reporting.

How Does NH Make Money?

  • Software-as-a-Service (SaaS): NantHealth generates revenue through subscription fees for its Eviti and NaviNet platforms.
  • Data Solutions: The company offers data analysis, reporting, and professional services through its Quadris solution, generating revenue through service fees.
  • Enterprise Solutions: NantHealth provides enterprise-grade network monitoring solutions through OpenNMS, generating revenue through licensing and support agreements.

What Industry Does NH Operate In?

NantHealth operates within the healthcare IT sector, which is characterized by increasing demand for solutions that improve efficiency, reduce costs, and enhance patient outcomes. The market is driven by factors such as the growing adoption of electronic health records (EHRs), the need for better data analytics, and the increasing focus on value-based care. The competitive landscape includes established players like Allscripts Healthcare Solutions and Cerner Corporation, as well as emerging companies offering specialized solutions. NantHealth differentiates itself through its focus on cancer care management with the Eviti platform and its payer-provider collaboration platform, NaviNet.

Who Are NH's Key Customers?

  • Healthcare Providers: Physicians, hospitals, and cancer centers use NantHealth's Eviti platform for clinical decision support.
  • Healthcare Payers: Insurance companies and managed care organizations use NaviNet to streamline communication and pre-authorization processes.
  • Enterprise Clients: Organizations with large networks use OpenNMS for network monitoring.
Model self-rating on this text: 66% (not a measure of the evidence) Updated: May 10, 2026

Research confidence

Low 0/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price 15 days old
  • No filing on record
  • No analyst coverage

Company Profile

NantHealth, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Morrisville, US. The company is led by CEO Patrick Soon-Shiong F.A.C.S., FACS, FRCS (C),. NH has traded publicly since 2016.

ROE 35%

Key Financial Metrics

Return on equity for NantHealth, Inc. stands at 35.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -42.5%, showing how much profit it generates from its asset base. A current ratio of 0.35 means current liabilities exceed short-term assets, a liquidity point worth watching.

F-Score 3/9

Financial Health

NantHealth, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -13.11 places it in the distress zone, a signal of elevated financial risk.

Net buying

Insider Activity

The most recent 11 insider filings for NantHealth, Inc. break down as 3 sales and 8 purchases. On net that is roughly 17.3M shares acquired (about $16.5M) — insiders putting money in tends to read as conviction.

NH Financials

Fundamental Snapshot

Return on Equity (TTM)
+35.0%
Current Ratio
0.4

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Comprehensive clinical decision support with Eviti platform.
  • Established payer-provider communication platform with NaviNet.
  • SaaS-based business model provides recurring revenue.
  • Offers data analytics solutions through Quadris.

Bear Case

  • Negative profit margin (-101.2%) indicates financial instability.
  • High beta (1.82) suggests high volatility compared to the market.
  • Dependence on NantWorks, LLC.
  • Limited geographic presence compared to larger competitors.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · May 2026

NH Latest News

Leadership: Patrick Soon-Shiong F.A.C.S., FACS, FRCS (C),

CEO

Patrick Soon-Shiong is a surgeon, scientist, and entrepreneur. He received his medical degree from the University of Witwatersrand in South Africa. He is the founder of NantWorks, a network of health, energy, commerce and communication companies. He previously founded Abraxis BioScience, which was acquired by Celgene. He has also been involved in various philanthropic endeavors, including cancer research and healthcare initiatives.

Track Record: Under Dr. Soon-Shiong's leadership, NantHealth has focused on developing and deploying technology solutions to improve healthcare delivery. Key milestones include the development of the Eviti and NaviNet platforms, aimed at streamlining clinical decision support and payer-provider communication. The company has also focused on expanding its data analytics capabilities through the Quadris solution.

NH Healthcare Stock FAQ

What happened to NantHealth, Inc. (NH) stock?

NantHealth, Inc. (NH) no longer trades on public markets. It was delisted in January 2025. The figures below are historical and are not a current quote.

Can I still buy NH shares?

No. NH stopped trading on public markets in January 2025, so the shares are not available through a broker. Anything you see quoted for NH elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before NH stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to NantHealth, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does NantHealth, Inc. do?

NantHealth, Inc. operates as a healthcare IT company, providing solutions to streamline clinical decision support and enhance payer-provider communication. Its core offerings include the Eviti platform, a SaaS-based clinical decision support tool that centralizes clinical content, treatment cost data, and treatment toxicity data, primarily focused on cancer care.

What do analysts say about NH stock?

Analyst coverage of NantHealth, Inc. Key valuation metrics and growth considerations are focused on the company's ability to scale its SaaS solutions, particularly Eviti and NaviNet, and achieve profitability.

What are the main risks for NH?

NantHealth, Inc. faces several risks, including intense competition from established healthcare IT vendors, regulatory changes impacting reimbursement and data privacy, and potential cybersecurity threats.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information.
  • Competitive landscape assessment is based on publicly available information and may not be exhaustive.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover